許 金旺

Medicine & Life Sciences

1. Acute Lung Injury 100%
2. Meta-Analysis 90%
3. Hospital Emergency Service 89%
4. Systematic Reviews 72%
5. Reperfusion 66%
6. baicalein 62%
7. Ischemia 51%
8. Randomized Controlled Trials 44%
9. Imipenem 43%
10. Enterobacteriaceae 41%
11. sphingosine 1-phosphate 41%
12. Ventilator-Associated Pneumonia 40%
13. Pneumonia 40%
14. Confidence Intervals 40%
15. Cohort Studies 40%
16. Lung 40%
17. Tigecycline 38%
18. Intensive Care Units 38%
19. Nitric Oxide 38%
20. Cardiac Myocytes 37%
21. Emergencies 37%
22. Reperfusion Injury 37%
23. Hyperglycemia 36%
24. Myocardial Infarction 35%
25. Grape Seed Proanthocyanidins 35%
26. Glycated Hemoglobin A 34%
27. Bacteremia 34%
28. Glucose 34%
29. Klebsiella pneumoniae 33%
30. Acinetobacter baumannii 33%
31. Emergency Medicine 33%
32. Spinal Epidural Hematoma 33%
33. Pyogenic Liver Abscess 32%
34. Hypokalemic Periodic Paralysis 32%
35. Dissecting Aneurysm 31%
36. baicalin 31%
37. Hypoglycemia 30%
38. Enterobacter cloacae 30%
39. Sulbactam 30%
40. Wounds and Injuries 29%
41. Lung Injury 29%
42. Chest Pain 28%
43. Air Embolism 28%
44. Odds Ratio 27%
45. Marfan Syndrome 27%
46. Therapeutics 26%
47. Mortality 26%
48. Virtual Reality 25%
49. Carbapenems 24%
50. Lidocaine 24%